Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: Implications for diagnosis

Human Reproduction

Volumn 26, Issue 6, 2011, Pages 1469-1477

  Hickey, M ^a   Doherty, D A ^b   Atkinson, H ^b   Sloboda, D M ^c   Franks, S ^d   Norman, R J ^e   Hart, R ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

^e UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

adolescence; diagnosis; hyperandrogenism; polycystic ovary syndrome

Indexed keywords

SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADOLESCENT; ANDROGEN EXCESS SOCIETY CRITERIA; ARTICLE; BIOCHEMISTRY; BODY MASS; CAUCASIAN; CLINICAL FEATURE; COHORT ANALYSIS; ECHOGRAPHY; FEMALE; FERRIMAN GALLWEY SCORE; HUMAN; HYPERANDROGENISM; IMMUNOASSAY; MAJOR CLINICAL STUDY; MENARCHE; MENSTRUAL IRREGULARITY; MORPHOLOGY; NATIONAL INSTITUTES OF HEALTH CRITERIA; OVARY POLYCYSTIC DISEASE; PROSPECTIVE STUDY; RATING SCALE; ROTTERDAM CRITERIA; SCORING SYSTEM; TESTOSTERONE BLOOD LEVEL; WAIST HIP RATIO;

EID: 79957450017     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der102     Document Type: Article

References (48)

1. Apter D, Vihko R. Serum pregnenolone, progesterone, 17- hydroxyprogesterone, testosterone and 5 alpha-dihydrotestosterone during female puberty. J Clin Endocrinol Metab 1977;45:1039-1048. (Pubitemid 8238620)
2. Apter D, Vihko R. Premenarcheal endocrine changes in relation to age at menarche. Clin Endocrinol (Oxf) 1985;22:753-760. (Pubitemid 15046176)
3. Azziz R. Controversy in clinical endocrinology: Diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are premature. J Clin Endocrinol Metab 2006;91:781-785. (Pubitemid 43357736)
4. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-2749. (Pubitemid 38766360)
5. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE et al..; Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report. Fertil Steril 2009;91:456-488.
6. Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: International consensus definitions. Hum Reprod Update 2003;9:505-514. (Pubitemid 38072143)
7. Blank SK, Helm KD, McCartney CR, Marshall JC. Polycystic ovary syndrome in adolescence. Ann N Y Acad Sci 2008;1135:76-84. (Pubitemid 351862121)
8. Blank SK, McCartney CR, Chhabra S, Helm KD, Eagleson CA, Chang RJ, Marshall JC. Modulation of gonadotropin-releasing hormone pulse generator sensitivity to progesterone inhibition in hyperandrogenic adolescent girls-implications for regulation of pubertal maturation. J Clin Endocrinol Metab 2009;94:2360-2366.
9. Clayton RN, Ogden V, Hodgkinson J, Worswick L, Rodin DA, Dyer S, Meade TW. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin Endocrinol (Oxf) 1992;37:127-134.
10. Davison SL, Bell R. Androgen physiology. Semin Reprod Med 2006; 24:71-77. (Pubitemid 43736517)
11. Farquhar CM, Birdsall M, Manning P, Mitchell JM, France JT. The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Aust N Z J Obstet Gynaecol 1994;34:67-72. (Pubitemid 24061513)
12. Ferriman D, Galwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440-1447.
13. Franks S. Polycystic ovary syndrome. N Engl J Med 1995;333:853-861.
14. Franks S. Polycystic ovary syndrome in adolescents. Int J Obes (Lond) 2008; 32:1035-1041. (Pubitemid 351986206)
15. Hart R, Sloboda DM, Doherty DA, Norman RJ, Atkinson HC, Newnham JP, Dickinson JE, Hickey M. Circulating maternal testosterone concentrations at 18 weeks of gestation predict AMH in adolescence. Fertil Steril 2010;94:1544-7.
16. Hickey M, Sloboda DM, Atkinson HC, Doherty DA, Franks S, Norman RJ, Newnham JP, Hart R. The relationship between maternal and umbilical cord androgen levels and Polycystic Ovary Syndrome in adolescence: A prospective cohort study. J Clin Endocrinol Metab 2009;94:3714-3720.
17. Holm K, Laursen EM, Brocks V, Müller J. Pubertal maturation of the internal genitalia: An ultrasound evaluation of 166 healthy girls. Ultrasound Obstet Gynecol 1985;6:175-181.
18. Huang A, Brennan K, Azziz R. Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria. Fertil Steril 2010;93:1938-1941.
19. Ibanez L, Valls C, Marcos MV, Ong K, Dunger DB, De Zegher F. Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: Effects of prepubertal initiation and postpubertal discontinuation of metformin treatment. J Clin Endocrinol Metab 2004;89:4331-4337. (Pubitemid 39244434)
20. Johnstone EB, Rosen MP, Neril R, Trevithick D, Sternfeld B, Murphy R, Addauan-Andersen C, McConnell D, Pera RR, Cedars MI. The polycystic ovary post-rotterdam: A common, age-dependent finding in ovulatory women without metabolic significance. J Clin Endocrinol Metab 2010;95:4965-4972.
21. Khan U. Polycystic ovary syndrome in adolescents. J Pediatr Adolesc Gynecol 2007;20:101-104. (Pubitemid 46518186)
22. Koivunen R, Laatikainen T, Tomás C, Huhtaniemi I, Tapanainen J, Martikainen H. The prevalence of polycystic ovaries in healthy women. Acta Obstet Gynecol Scand 1999;78:137-141. (Pubitemid 29067192)
23. Kristensen SL, Ramlau-Hansen CH, Ernst E, Olsen SF, Bonde JP, Vested A, Toft G. A very large proportion of young Danish women have polycystic ovaries: Is a revision of the Rotterdam criteria needed? Hum Reprod 2010;25:3117-3122.
24. Laitinen J, Taponen S, Martikainen H, Pouta A, Millwood I, Hartikainen AL, Ruokonen A, Sovio U, McCarthy MI, Franks S et al. Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms. Int J Obes Relat Metab Disord 2003;27:710-715. (Pubitemid 36712955)
25. Legro RS, Schlaff WD, Diamond MP, Coutifaris C, Casson PR, Brzyski RG, Christman GM, Trussell JC, Krawetz SA, Snyder PJ et al. Testosterone assays in women with polycystic ovary syndrome: Precision and correlation with hirsutism. Clin Endocrinol Metab 2010;95:5305-5313.
26. Lucky AW, Biro FM, Daniels SR, Cedars MI, Khoury PR, Morrison JA. The prevalence of upper lip hair in black and white girls during puberty: A new standard. J Pediatr Endocrinol Metab 2001;138:134-136. (Pubitemid 32097158)
27. MarchWA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25:544-551.
28. Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol (Oxf) 1999;51:779-786. (Pubitemid 30050829)
29. Palmert MR, Gordon CM, Kartashov AI, Legro RS, Emans SJ, Dunaif A. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87: 1017-1023. (Pubitemid 36121058)
30. Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries-a common finding in normal women. Lancet 1988;1:870-872. (Pubitemid 18092411)
31. Rosenfield RL, Ghai K, Ehrmann DA, Barnes RB. Diagnosis of the polycystic ovary syndrome in adolescence: Comparison of adolescent and adult hyperandrogenism. J Pediatr Endocrinol Metab 2000;13(Suppl 5):1285-1289.
32. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81:19-25.
33. Silfen ME, Denburg MR, Manibo AM, Lobo RA, Jaffe R, Ferin M, Levine LS, Oberfield SE. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): Comparison between nonobese and obese adolescents. J Clin Endocrinol Metab 2003;88:4682-4688. (Pubitemid 37357512)
34. Sloboda DM, Hart R, Doherty DA, Pennell CE, Hickey M. Age at menarche: Influences of prenatal and postnatal growth. J Clin Endocrinol Metab 2007;92:46-50. (Pubitemid 46067507)
35. Sloboda DM, Hart R, Hickey M. Developmental Origins of Reproductive Health. In: Newnham JP, Ross M. (ed). Early Life Origins of Human Health and Disease. Karger, 2009.
36. Southam AL, Richart RM. The prognosis for adolescents with menstrual abnormalities. Am J Obstet Gynecol 1966;94:637-645.
37. Taponen S, Ahonkallio S, Martikainen H, Koivunen R, Ruokonen A, Sovio U, Hartikainen AL, Pouta A, Laitinen J, King V et al.. Prevalence of polycystic ovaries in women with self-reported symptoms of oligomenorrhoea and/or hirsutism: Northern Finland Birth Cohort 1966 Study. Hum Reprod 2004;19:1083-1088. (Pubitemid 38618486)
38. Thiboutot D, Archer DF, Lemay A, Washenik K, Roberts J, Harrison DD. A randomized, controlled trial of a low-dose contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment. Fertil Steril 2001;76:461-468.
39. Treloar AE. Menstrual cyclicity and the pre-menopause. Maturitas 1981; 3:249-264. (Pubitemid 12145694)
40. van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 year old adolescents. Hum Reprod Update 1999a;14:2223-2229. (Pubitemid 29425403)
41. van Hooff MH, van der Meer M, Lambalk CB, Schoemaker J. Variation of luteinizing hormone and androgens in oligomenorrhoea and its implications for the study of polycystic ovary syndrome. Hum Reprod Update 1999b;14:1684-1689. (Pubitemid 29358677)
42. van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin. Fertil Steril 2000a;74:49-58. (Pubitemid 30427272)
43. van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Insulin, androgen, and gonadotropin concentrations, body mass index, and waist to hip ratio in the first years after menarche in girls with regular menstrual cycles, irregular menstrual cycles, or oligomenorrhea. J Clin Endocrinol Metab 2000b;85:1394-1400. (Pubitemid 32289479)
44. van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Predictive values of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at aged 15 years for oligo-amenorrhoea at aged 18 years. Human Reproduction 2004; 19:383-392. (Pubitemid 38220012)
45. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672. (Pubitemid 30645223)
46. Wei S, Schmidt MD, Dwyer T, Norman RJ, Venn AJ. Obesity and menstrual irregularity: Associations with SHBG, testosterone and insulin. Obesity (Silver Spring) 2009;17:1070-6.
47. Yildiz BO, Bolour S, Woods K, Moore A, Azziz R. Visually scoring hirsutism. Hum Reprod Update 2010;16:51-64.
48. Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In: Dunaif A (ed). Polycystic Ovary Syndrome. Boston: Blackwell Scientific, 1995,377-384.